Side Effects
GLP-1 Vision Loss Lawsuits: About 3 Extra Cases per 10,000
Lawsuits put GLP-1 vision loss back in the news. See the absolute risk, what regulators concluded in 2025, and why the US label differs.
Side Effects
What is common, what is rare, and when a symptom is worth a call to the prescriber.
Side Effects
Anyone Can Print a Lab Report. Only a Pharmacy Can Hold a License.
A $95 peptide vial had a brand, a shop and a lab report. See which signals are easy to fake and what a licensed pharmacy is really held to.
Side Effects
GLP-1s and a Rare Brain Injury: 13 of 15 Cases Had a Warning Sign First
A study found 15 cases of a rare B1 deficiency brain injury in GLP-1 users. See what the data shows and the warning sign 13 of them had first.
Side Effects
GLP-1s and Drinking Less: What the Research Actually Shows
Do GLP-1s reduce drinking? A 2026 trial says yes for people with obesity, but two trials missed their goal. What the evidence really shows.
Medications
Gallbladder Problems on GLP-1s: Why They Happen and the Warning Signs
GLP-1 medicines slightly raise gallstone and gallbladder risk from fast weight loss. See how common it is, how to lower risk, and warning signs.
Side Effects
GLP-1s and Menopause: Weight, Muscle, and Bone Health
How GLP-1 medications affect weight, muscle, and bone in menopause, plus steps midlife women can take to protect lean mass and bone health.
More in Side Effects
- Medications
Why You Start Moving Less on a GLP-1 and How to Fix It
A 2026 study found people take fewer steps after starting a GLP-1. Learn why it happens and easy ways to stay active and protect muscle.
- Medications
Honey, Stevia, and Sugar: Which Is Healthier?
Honey, agave, stevia, and monk fruit get marketed as better than sugar. See which are natural sugars and what the research really shows.
- Medications
Can GLP-1 Medications Help People With Cancer? What a New Study Shows
A study found about 60% lower mortality among women with breast cancer who used GLP-1 medications. What the research shows, and what it doesn't prove.
- Side Effects
Are Peptides Safe? A Plain-Language Guide to What's Legitimate and What's Risky
Some peptides are FDA-approved medicines and some "research" peptides are risky. A plain-language guide to telling safe sources from unsafe ones.
- Medications
Ozempic Personality: What the Research Actually Says About GLP-1s and Your Mood
Worried about “Ozempic personality”? The FDA’s 2026 review of 107,910 patients tells a more reassuring story than the headlines do.
- Medications
The Hidden Cost of Taking a Break from Your GLP-1 Medication
A new mouse study suggests pausing a GLP-1 makes restarts less effective. Here is how strong the evidence is and what to think about before a break.
